Tuesday, 29 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14499
Articles
Company
Drug
Huadong Medicine Files for NMPA Approval of Ranibizumab Biosimilar
June 3, 2025
Company
Deals
Hansoh Pharmaceutical Partners with Regeneron for HS-20094 Global Rights
June 3, 2025
Company
Drug
CSPC Pharmaceutical’s JMT101 Receives Breakthrough Therapy Designation for Colorectal Cancer
June 3, 2025
Company
Drug
Zai Lab Presents ZL-1310 Clinical Results for Small Cell Lung Cancer at ASCO
June 3, 2025
Company
Drug
Alphamab Oncology Presents JSKN003 Clinical Data at 2025 ASCO Annual Meeting
June 3, 2025
Company
Drug
Innovent Biologics Presents IBI363 Clinical Results at 2025 ASCO Annual Meeting
June 3, 2025
Company
Drug
BeOne Medicines Wins Conditional Approval for Ziihera in HER2-Positive BTC
June 3, 2025
Company
Deals
LongBio Pharma Secures RMB 200 Million Series C Funding for Clinical Studies
June 3, 2025
Company
Deals
Neowise Biotech Licenses TCR Molecule to BeOne Medicines for Next-Gen Cell Therapy
June 3, 2025
Company
Deals
Nurix Therapeutics Announces Sanofi’s Acquisition of STAT6 Program Rights
June 3, 2025
Company
Drug
MSD Presents Zilovertamab Vedotin Results at ASCO Annual Meeting
June 3, 2025
Company
Deals
Hanx Bio Files for Hong Kong IPO with ICBC International as Sole Sponsor
June 3, 2025
1
2
…
350
351
352
353
354
…
1,208
1,209
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
